An MRI of a brain tumor
inviCRO has raised $45.8 million in its first disclosed financing. The money will be used to offer imaging services and analysis to aid drug research and development, according to a regulatory filing.
This news comes just after the Boston-based startup acquired Molecular Neuroimaging (MNI), expanding its neurological imaging options.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
As Fierce Medical Devices reported, inviCRO helped open the Translational Imaging Center in Mattawan, MI that it co-manages with MNI Research and 3D Imaging; inviCRO provides molecular imaging, while 3D imaging offers radiopharmaceutical services and MNI contributes its CRO services.
The company is continuing to expand, considering last year it also acquired a Seattle-based histology team.
The Mechanics of a More Connected Healthcare Ecosystem [Video]
Arbiter’s Anjali Jameson on hospital and payer alignment.